Westwood Holdings »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Westwood Holdings

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Westwood Holdings from 13F filings

Historical chart of Westwood Holdings investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Westwood Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Westwood Holdings

Quarter filed Position value Share count Share price at filing
2023-09-30 $2.1M 2.3M 0.94

More positions owned by Westwood Holdings

Energy Transfer Com Ut Ltd Ptn (ET)
Microsoft Corporation (MSFT)
Cheniere Energy Com New (LNG)
Johnson & Johnson (JNJ)
Enbridge (ENB)
JPMorgan Chase & Co. (JPM)
Targa Res Corp (TRGP)
Apple (AAPL)
Abbott Laboratories (ABT)
Enterprise Products Partners (EPD)
Bank of America Corporation (BAC)
Honeywell International (HON)
Chevron Corporation (CVX)
Williams Companies (WMB)
Kinder Morgan (KMI)

View all positions for Westwood Holdings

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Citadel Advisors
Polar Securities
Millennium Management
Bank Of Montreal
Kohlberg Kravis Roberts & Co
D. E. Shaw & Co
Absolute Investment Advisers
SSI Investment Management
CSS
Readystate Asset Management
CNH Partners

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1